Clinical trial
Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration
NCT02953600 is registered in ClinicalTrials.gov with Taipei Medical University WanFang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Effect of Cyanobacteria Patients With Chronic Hepatitis B Surface Antigen Quantitative Concentration
- Lead sponsor
- Taipei Medical University WanFang Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- November 30, 2016
- Completion date
- August 31, 2017
- Enrollment
- 72 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hbv carrier